A study has pointed out that radioactive iodine (RAI), thyroid-stimulating hormone (TSH) levels, luteinizing hormone (LH) and follicle-stimulating hormone (FSH) homology, immune system decline, and genetic variation are associated with poor prognosis in thyroid cancer patients of advanced age (23). The gene discussed is BRD2; the disease is thyroid cancer.